Effects of Inspiratory Muscle Training on Cardiovascular Function in Hypertension.
TREMVEN
Inspiratory Muscle Training: Effects on Blood Pressure, Heart Rate Variability and Functional Capacity in Hypertensive Patients.
1 other identifier
interventional
14
1 country
1
Brief Summary
The purpose of this study is to determine inspiratory muscle training effects on blood pressure, functional capacity and quality of life in hypertensive patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 29, 2010
CompletedFirst Posted
Study publicly available on registry
November 30, 2010
CompletedNovember 30, 2010
October 1, 2010
1.3 years
November 29, 2010
November 29, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences on blood pressure levels
Blood pressure behavior is accessed by Ambulatory Blood Pressure Monitorying.
eight weeks
Secondary Outcomes (3)
improvement of Heart rate variability
eight weeks
improvement of quality of life
eigth weeks
Improvement of Functional Capacity
eight weeks
Study Arms (1)
Inspiratory Muscle Training
EXPERIMENTALIt will me performed a loaded training of ventilatory muscles in patients with Hypertension. Its is done with the practice of breathing exercises associated to an training device, specific for this kind of intervention.
Interventions
Breathing exercises associated to the use of a training device with predetermined pressure load, daily, 30 minutes per day, during eight weeks.
Eligibility Criteria
You may qualify if:
- Age between 25 and 70
- Hypertension in all stages:
- Prehypertension - Systolic blood pressure (SBP) of 120 to 139 and/or diastolic blood pressure (DBP) of 80 to 89 mmHg 2.2.Stage 1 Hypertension - SBP of 140 to 159 mmHg and/or DBP of 90 to 99 mmHg 2.3.Stage 2 Hypertension - SBP ≥ 160 mmHg and/or DBP ≥ 100 mmHg
You may not qualify if:
- Disagreement with consent form
- Thoracic pain (angina)
- Hypertension instability
- Antihypertensive drugs alterations within 30 days before or during the study
- Diabetes
- Chronic pulmonary obstructive disease
- Incapability of executing the functional tests
- Asthma
- Chronic Heart Failure
- Obesity
- Cardiovascular diseases complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pedro Dal Lago
Porto Alegre, Rio Grande do Sul, 90050-170, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 29, 2010
First Posted
November 30, 2010
Study Start
March 1, 2009
Primary Completion
July 1, 2010
Last Updated
November 30, 2010
Record last verified: 2010-10